Systematic Review and Meta-Analysis of Interventions to Improve Access and Coverage of Adolescent Immunizations.
Vaccination strategies are among the most successful and cost-effective public health strategies for preventing disease and death. Until recently, most of the existing immunization programs targeted infants and children younger than 5 years which have successfully resulted in reducing global infant and child mortality. Adolescent immunization has been relatively neglected, leaving a quarter of world's population underimmunized and hence vulnerable to a number of preventable diseases. In recent years, a large number of programs have been launched to increase the uptake of different vaccines in adolescents; however, the recommended vaccination coverage among the adolescent population overall remains very low, especially in low- and middle-income countries. Adolescent vaccination has received significantly more attention since the advent of the human papillomavirus (HPV) vaccine in 2006. However, only half of the adolescent girls in the United States received a single dose of HPV vaccine while merely 43% and 33% received two and three doses, respectively. We systematically reviewed literature published up to December 2014 and included 23 studies on the effectiveness of interventions to improve immunization coverage among adolescents. Moderate-quality evidence suggested an overall increase in vaccination coverage by 78% (relative risk: 1.78; 95% confidence interval: 1.41-2.23). Review findings suggest that interventions including implementing vaccination requirement in school, sending reminders, and national permissive recommendation for adolescent vaccination have the potential to improve immunization uptake. Strategies to improve coverage for HPV vaccines resulted in a significant decrease in the prevalence of HPV by 44% and genital warts by 33%; however, the quality of evidence was low. Analysis from single studies with low- or very low-quality evidence suggested significant decrease in varicella deaths, measles incidence, rubella susceptibility, and incidence of pertussis while the impact was nonsignificant for incidence of mumps with their respective vaccines. Further rigorous evidence is needed to evaluate the effectiveness of strategies to improve immunization uptake among adolescents from low- and middle-income countries.
Division of Women and Child Health, Aga Khan University, Karachi, Pakistan.
Jai K
JK
Das
Division of Women and Child Health, Aga Khan University, Karachi, Pakistan.
Rehana A
RA
Salam
Division of Women and Child Health, Aga Khan University, Karachi, Pakistan.
Ahmed
A
Arshad
Robinson Research Institute, University of Adelaide, Adelaide, Australia.
Zohra S
ZS
Lassi
Centre for Global Child Heath, The Hospital for Sick Children, Toronto, Canada; Center of Excellence in Women and Child Health, The Aga Khan University, Karachi, Pakistan. Electronic address: zulfiqar.bhutta@sickkids.ca.
Zulfiqar A
ZA
Bhutta
Adolescent health; Immunization; National permissive recommendation; National vaccination; Reminders; School vaccination; Vaccination
Public Health Rep. 2004 Mar-Apr;119(2):163-9
15192903
Am J Public Health. 2004 Jun;94(6):978-84
15249302
N Engl J Med. 2005 Feb 3;352(5):450-8
15689583
J Adolesc Health. 2006 Mar;38(3):321-7
16521332
J Adolesc Health. 2007 Aug;41(2):119-25
17659214
Int J Epidemiol. 2010 Apr;39 Suppl 1:i21-31
20348122
Am J Public Health. 2010 Sep;100(9):1635-40
20634463
J Infect Dis. 2011 Jul;204 Suppl 1:S455-62
21666199
Bull World Health Organ. 2011 Sep 1;89(9):666-74
21897487
Sex Transm Infect. 2011 Dec;87(7):544-7
21970896
J Pediatr Health Care. 2012 Mar;26(2):92-101
22360928
Am J Public Health. 2012 Feb;102(2):e15-21
22390457
Am J Public Health. 2012 May;102(5):833-5
22420808
Vaccine. 2012 May 21;30(24):3546-56
22480928
Pediatrics. 2012 Jun;129(6):e1446-52
22566414
Pediatrics. 2012 Jun;129(6):e1437-45
22566415
Pediatrics. 2012 Jun;129(6):1056-63
22566425
Bull World Health Organ. 2012 May 1;90(5):365-72
22589570
Vaccine. 2012 Jul 13;30(33):4960-3
22652406
Bull World Health Organ. 2012 Aug 1;90(8):623-8
22893746
Pediatrics. 2012 Dec;130(6):e1567-74
23129075
Vaccine. 2012 Nov 20;30 Suppl 5:F12-23
23199955
Bull World Health Organ. 2012 Dec 1;90(12):874-5
23284191
Sex Transm Dis. 2013 Feb;40(2):130-5
23324976
Acad Pediatr. 2013 May-Jun;13(3):204-13
23510607
Vaccine. 2013 Jun 10;31(26):2816-21
23602667
J Infect Dis. 2013 Aug 1;208(3):385-93
23785124
J Adolesc Health. 2013 Oct;53(4):492-7
23809613
Vaccine. 2013 Aug 20;31(37):3786-804
23830973
BMC Public Health. 2013 Jul 09;13:640
23837819
MMWR Morb Mortal Wkly Rep. 2013 Jul 26;62(29):591-5
23884346
Vaccine. 2013 Dec 17;32(1):26-32
24211166
JAMA Pediatr. 2014 Jan;168(1):76-82
24276343
Lancet Glob Health. 2014 Jul;2(7):e406-14
25103394
JAMA Oncol. 2015 Jul;1(4):505-27
26181261
J Adolesc Health. 2016 Oct;59(4S):S11-S28
27664592
J Adolesc Health. 2016 Oct;59(4S):S29-S39
27664593
J Adolesc Health. 2016 Oct;59(4S):S4-S10
27664594
J Adolesc Health. 2016 Oct;59(4S):S49-S60
27664596
J Adolesc Health. 2016 Oct;59(4S):S61-S75
27664597
J Adolesc Health. 2016 Oct;59(4S):S76-S87
27664598
J Adolesc Health. 2016 Oct;59(4S):S88-S92
27664599
Can Med Assoc J. 1985 Aug 1;133(3):215-6
4016629
Am J Public Health. 1982 Jul;72(7):710-3
7091461
Arch Fam Med. 1994 Mar;3(3):257-62
8180716